SummaryAvalere experts discussed the marketplace for COVID-19 vaccines and therapeutics, including key decision points for regulatory pathways, pricing, and distribution scenarios for optimal US and EX-US market access.
With hundreds of vaccine and therapeutic candidates in the pipeline, planning ahead for patient access is vital. This uncharted territory provokes important questions about regulatory pathways, pricing, government procurement, coverage, access, distribution, and more. Avalere experts explored these questions and tipping points, as well as the necessary market access strategies.
- FDA regulatory considerations and downstream implications
- Coverage and access challenges
- Pricing, procurement, and distribution scenarios
- Potential 2020 election impacts on the COVID-19 response
produces measurable results. Let's work together.